SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Vaccination Rates Among Utah Community Health Centers
2 other identifiers
interventional
65,300
1 country
1
Brief Summary
SCALE-UP Utah is a community-academic partnership to address COVID-19 among Utah community health centers. The long-term objective of the project is to increase the reach, acceptance, and uptake of COVID-19 vaccines among Utah's Community Health Center patient population. The study will compare two practical, feasible, scalable interventions to increase COVID-19 vaccine uptake in Utah Community Health Centers:
- 1.Text Messaging (TM): population health management (PHM) intervention that analyzes EHR data to automatically identify patients eligible for COVID-19 vaccination and uses bi-directional text messaging to help connect patients to a vaccination site;
- 2.Patient Navigation (PN): PHM intervention to increase vaccination uptake among eligible patients (identified via TM) using patient navigation (e.g., motivating patients, addressing logistics and barriers).
- 3.Implement and evaluate PHM interventions for increasing the uptake of COVID-19 vaccinations among CHC patients across Utah. Our primary outcome, Uptake-Eligible, is defined as the proportion of patients who receive a COVID-19 vaccination out of those who meet eligibility criteria for vaccination. Our study hypothesis is that patients in the TM+PN cohort will have higher rates of uptake-eligible than those in the TM cohort.
- 4.Examine implementation effectiveness outcomes, as well as characteristics of both clinics and patients that may influence intervention effects and implementation outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable covid19
Started Mar 2021
Longer than P75 for not_applicable covid19
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 29, 2021
CompletedFirst Submitted
Initial submission to the registry
April 7, 2021
CompletedFirst Posted
Study publicly available on registry
June 25, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 17, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2023
CompletedResults Posted
Study results publicly available
December 12, 2025
CompletedDecember 12, 2025
December 1, 2025
1.2 years
April 7, 2021
August 25, 2023
December 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Uptake-Total
Proportion of patients who receive a COVID-19 vaccine out of the total patient population
12 months
Secondary Outcomes (3)
Reach-TM Engage
12 months
Reach-PN Engage- Logistics Assistance
12 months
Reach-PN Engage- Requested Navigation
12 months
Study Arms (2)
Text-Messaging (TM)
ACTIVE COMPARATORPopulation health management intervention that analyzes electronic health record data to automatically identify participants who are eligible for the COVID-19 vaccine and proactively reach those participants for vaccine scheduling. This is a bi-directional text messaging system.
Text-Messaging plus Patient Navigation
ACTIVE COMPARATORPopulation health management intervention that includes the same bi-directional text-messaging system as Arm 1 (the text messaging condition) with the addition of patient navigation. Patient navigation includes real-time assistance from a community health worker to address barriers, provide motivation, and assist with logistics of COIVD vaccination.
Interventions
Participants in the TM condition will receive HIPAA-compliant bidirectional text messages. These texts will include a brief message alerting patients that they are eligible to receive the vaccine and asking participants if they would like to schedule a vaccine. Participants who reply "yes" will receive an additional message with information about how and where to register for the vaccine. This information will vary depending on local availability. Participants who reply "no" will receive a text requesting they contact their local clinic when they decide to receive the vaccine.
Participants in the PN condition will receive a message alerting them that a Community Health Worker will contact them to assist with the process of scheduling a vaccine. At this time the participant has the option to opt-out of this follow up phone call. The patient navigation from the Community Health Worker includes practical advice in addressing barriers to vaccination such as logistics and transportation, as well as fear, skepticism, and hesitancy.
Eligibility Criteria
You may qualify if:
- current patient of a participating community health center
- have a working cellphone,
- have phone number listed in existing electronic medical record at their participating clinic
- speak English or Spanish.
You may not qualify if:
- Minors
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Utah Department of Healthcollaborator
- University of Utahlead
- Association for Utah Community Healthcollaborator
- National Institutes of Health (NIH)collaborator
- National Center for Advancing Translational Sciences (NCATS)collaborator
Study Sites (1)
Huntsman Cancer Institute/ University of Utah
Salt Lake City, Utah, 84112, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
During the analysis portion of this project, the investigators decided that the original primary outcome and a secondary outcome were duplicative due to the eventual widespread availability of the COVID-19 Vaccine. Therefore, the investigators decided to delete the primary outcome and keep the secondary outcome as the primary. Study protocol and Statistical Analytic plan were amended to reflect the changes.
Results Point of Contact
- Title
- Dr. David Wetter
- Organization
- Huntsman Cancer Institute at University of Utah
Study Officials
- PRINCIPAL INVESTIGATOR
David Wetter, MS, PhD
University of Utah
- PRINCIPAL INVESTIGATOR
Rachel Hess, MD, MS
University of Utah
- PRINCIPAL INVESTIGATOR
Guilherme Del Fiol, MD, PhD
University of Utah
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Patients will not know if they are in the TM or TM+PN intervention arm.
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Center for Health Outcomes and Population Equity
Study Record Dates
First Submitted
April 7, 2021
First Posted
June 25, 2021
Study Start
March 29, 2021
Primary Completion
June 17, 2022
Study Completion
February 28, 2023
Last Updated
December 12, 2025
Results First Posted
December 12, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share